A. Blauvelt, A. Gottlieb, F. Fierens, F. Brock, S. Wiegratz, and H. Sofen, “Dose Adjustment Patterns in the Open-Label Extension Arms of Three Phase 3 Trials of Certolizumab Pegol in Psoriasis: CIMPASI-1, CIMPASI-2, and CIMPACT”, J of Skin, vol. 4, no. 6, p. s85, Oct. 2020.